Clinical research budgeting and reimbursement are increasingly complex areas for companies that sponsor clinical research and hospitals where research takes place:
- Issues of fair market value and kickbacks abound
- Insurance coverage is inconsistent
- CMS has updated requirements
- The Medicare Secondary Payer Rule has significant implications for subject injury reimbursement.
Financial implications and penalties for getting this wrong can be significant. At this interactive breakfast briefing, Faegre Baker Daniels Counsel Amy Judge-Prein will discuss how to avoid legal landmines when planning and executing clinical trials.
During this hour, Judge-Prein will review real-life examples and interact with your questions and experience.
Brought to you by the FDA practice group at Faegre Baker Daniels.
There is no fee to participate. An application for Minnesota CLE has been submitted.
Questions? Please contact Shannon Sprock at +1 303 607 3708 or shannon.sprock@FaegreBD.com.